Patents by Inventor Xiao-Xiong Lu

Xiao-Xiong Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESSES FOR THE PREPARATION OF 5-HT2C RECEPTOR AGONISTS
    Publication number: 20150210625
    Abstract: The present invention relates to processes and intermediates useful in the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin), a serotonin (5-HT) receptor modulator that is useful in the treatment of, for example, central nervous system disorders, such as obesity.
    Type: Application
    Filed: December 23, 2014
    Publication date: July 30, 2015
    Inventors: John A. DeMattei, Carlos Marlon, Ryan O. Castro, Tsung-Hsun Chuang, Mark Allen Hadd, Xiao-Xiong Lu, Mark Macias, Stephen M. Shaw
  • Processes for the preparation of 5-HTreceptor agonists
    Patent number: 8952197
    Abstract: The present invention relates to processes and intermediates useful in the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin), a serotonin (5-HT) receptor modulator that is useful in the treatment of for example, central nervous system disorders, such as obesity.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: February 10, 2015
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: John A. DeMattei, Carlos Marlon, Ryan O. Castro, Tsung-Hsun Chuang, Mark Allen Hadd, Xiao-Xiong Lu, Mark Macias, Stephen M. Shaw
  • Processes for the preparation of intermediates related to the 5-HTagonist ()-8-chloro-1-methyl-2,3,4,5-tetrahydro-1-3-benzazepine
    Patent number: 8822727
    Abstract: The present invention provides processes and intermediates useful in the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, a serotonin (5-HT) receptor agonist that is useful in the treatment or prophylaxis of, for example, central nervous system disorders, such as obesity.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: September 2, 2014
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Marlon V. Carlos, Ryan O. Castro, Tawfik Gharbaoui, Xiao-Xiong Lu, You-An Ma, Nicholas D. San Martin
  • PROCESSES FOR THE PREPARATION OF 5-HT2C RECEPTOR AGONISTS
    Publication number: 20120142967
    Abstract: The present invention relates to processes and intermediates useful in the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin), a serotonin (5-HT) receptor modulator that is useful in the treatment of, for example, central nervous system disorders, such as obesity.
    Type: Application
    Filed: June 17, 2010
    Publication date: June 7, 2012
    Inventors: John A. DeMattei, Marlon Carlos, Ryan O. Castro, Tsung-Hsun Chuang, Mark Allen Hadd, Xiao-Xiong Lu, Mark Macias, Stephen M. Shaw
  • PROCESS FOR THE PREPARATION OF INTERMEDIATES RELATED TOTHE 5-HT2C AGONIST (R)-8-CHLORO-1-METHYL-2,3,4,5,-TETRAHYDRO-1H-3-BENZAZEPINE
    Publication number: 20110015438
    Abstract: The present invention provides processes and intermediates useful in the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, a serotonin (5-HT) receptor agonist that is useful in the treatment or prophylaxis of, for example, central nervous system disorders, such as obesity.
    Type: Application
    Filed: March 3, 2009
    Publication date: January 20, 2011
    Inventors: Marlon V. Carlos, Ryan O. Castro, Tawfik Gharbaoui, Xiao-Xiong Lu, You-An Ma, Nicholas D. San Martin